Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03721458 · ClinicalTrials.gov registry record
Whole Genome Sequencing in the Neonatal Intensive Care Unit
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 3
- Enrollment target
NCT03721458 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 3 participants.
The verdict
NCT03721458 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
This research is being done to see if whole genome sequencing (WGS) improves the diagnosis of patients in the NICU. Using WGS in this way, which is relatively new, researchers at Penn State College of Medicine will look at approximately 5000 genes that are known to be associated with genetic diseases to see if the neonatal patient has a known disease causing mutation. Comparing the parents' DNA with the child's will help the investigators better understand the child's DNA.
Interventions
- OTHER Sequence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-05-28 |
| Est. Completion | 2020-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03721458
The ClinicalTrials.gov registry entry for NCT03721458 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sequence is the first listed.
NCT03721458 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03721458 about?
NCT03721458 is a clinical study titled "Whole Genome Sequencing in the Neonatal Intensive Care Unit". This research is being done to see if whole genome sequencing (WGS) improves the diagnosis of patients in the NICU. Using WGS in this way, which is relatively new, researchers at Penn State College of Medicine will look at approximately 5000 genes that are known to be associated with genetic disease...
What is the current status of trial NCT03721458?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2019-05-28. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03721458?
The interventions under investigation include: Sequence (OTHER).
Who is sponsoring clinical trial NCT03721458?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.